Journal
New England Journal of Medicine
Publication Date
2018
Volume
379
Issue
26
Inclusive Pages
2517-2528
Document Type
Open Access Publication
DOI
10.1056/NEJMoa1812836
Rights and Permissions
Woyach, J. A., Ruppert, A. S., Heerema, N. A., Zhao, W., Booth, A. M., Ding, W., . . . Byrd, J. C. (2018). Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL. New England Journal of Medicine, 379(26), 2517-2528. doi:10.1056/NEJMoa1812836 Copyright © 2018 Massachusetts Medical Society https://www.nejm.org/doi/full/10.1056/NEJMoa1812836?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed#article_Abstract
Recommended Citation
Bartlett, Nancy L., "Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL." New England Journal of Medicine. 379, 26. 2517-2528. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7884
nejmoa1812836_appendix.pdf (2404 kB)
nejmoa1812836_disclosures.pdf (469 kB)
nejmoa1812836_data-sharing.pdf (49 kB)
